BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang TW, Rhim H. Recent Advances in Tumor Ablation for Hepatocellular Carcinoma. Liver Cancer. 2015;4:176-187. [PMID: 26674766 DOI: 10.1159/000367740] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Han X, Wang R, Xu J, Chen Q, Liang C, Chen J, Zhao J, Chu J, Fan Q, Archibong E, Jiang L, Wang C, Liu Z. In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence. Biomaterials 2019;224:119490. [DOI: 10.1016/j.biomaterials.2019.119490] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
2 Kudo M. Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B. Liver Cancer 2016;5:91-6. [PMID: 27386427 DOI: 10.1159/000367768] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhang HM, Wang Y, Fatemi M, Insana MF. Assessing composition and structure of soft biphasic media from Kelvin-Voigt fractional derivative model parameters. Meas Sci Technol 2017;28:035703. [PMID: 28239236 DOI: 10.1088/1361-6501/aa5531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Huo Q, Ge C, Tian H, Sun J, Cui M, Li H, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J. Dysfunction of IKZF1/MYC/MDIG axis contributes to liver cancer progression through regulating H3K9me3/p21 activity. Cell Death Dis 2017;8:e2766. [PMID: 28471446 DOI: 10.1038/cddis.2017.165] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
5 Kao WY, Su CW, Chiou YY, Chiu NC, Liu CA, Fang KC, Huo TI, Huang YH, Chang CC, Hou MC, Lin HC, Wu JC. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation. Radiology. 2017;285:670-680. [PMID: 28562211 DOI: 10.1148/radiol.2017162382] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
6 Venkat SR, Mohan PP, Gandhi RT. Colorectal Liver Metastasis: Overview of Treatment Paradigm Highlighting the Role of Ablation. American Journal of Roentgenology 2018;210:883-90. [DOI: 10.2214/ajr.17.18574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
7 Deng HX, Huang JH, Lau WY, Ai F, Chen MS, Huang ZM, Zhang TQ, Zuo MX. Hydrochloric acid enhanced radiofrequency ablation for treatment of large hepatocellular carcinoma in the caudate lobe: Report of three cases. World J Clin Cases 2019; 7(4): 508-515 [PMID: 30842963 DOI: 10.12998/wjcc.v7.i4.508] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Tunissiolli NM, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino EC, da Silva RF, da Silva RC, Goloni-Bertollo EM. Hepatocellular Carcinoma: a Comprehensive Review of Biomarkers, Clinical Aspects, and Therapy. Asian Pac J Cancer Prev. 2017;18:863-872. [PMID: 28545181 DOI: 10.22034/apjcp.2017.18.4.863] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
9 Zhang N, Wang R, Hao J, Yang Y, Zou H, Wang Z. Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors. Int J Nanomedicine 2017;12:7273-89. [PMID: 29042775 DOI: 10.2147/IJN.S144058] [Cited by in Crossref: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kudo M. Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma. Liver Cancer 2016;5:1-7. [PMID: 26989655 DOI: 10.1159/000367760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
11 Wang SY, Chen XX, Li Y, Zhang YY. Application of Multimodality Imaging Fusion Technology in Diagnosis and Treatment of Malignant Tumors under the Precision Medicine Plan. Chin Med J (Engl) 2016;129:2991-7. [PMID: 27958232 DOI: 10.4103/0366-6999.195467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Yu J, Wu H, Meng X, Mu M, Dou J, Ahmed M, Liang P. Ultrasound-guided percutaneous microwave ablation of central intraductal papilloma: a prospective pilot study. International Journal of Hyperthermia 2019;36:605-11. [DOI: 10.1080/02656736.2019.1619849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kang TW, Lee MW, Song KD, Kim M, Kim SS, Kim SH, Ha SY. Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance. Korean J Radiol 2017;18:152-61. [PMID: 28096725 DOI: 10.3348/kjr.2017.18.1.152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
14 Kang TW, Lim HK, Cha DI. Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives. World J Gastroenterol 2018; 24(47): 5331-5337 [PMID: 30598578 DOI: 10.3748/wjg.v24.i47.5331] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
15 Carriero S, Della Pepa G, Monfardini L, Vitale R, Rossi D, Masperi A, Mauri G. Role of Fusion Imaging in Image-Guided Thermal Ablations. Diagnostics (Basel) 2021;11:549. [PMID: 33808572 DOI: 10.3390/diagnostics11030549] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Simmerman E, Chung J, Lawson A, Kruse E. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy. Journal of Surgical Research 2020;246:260-8. [DOI: 10.1016/j.jss.2019.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lee DH, Lee JM. Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. Korean J Radiol 2018;19:545-59. [PMID: 29962861 DOI: 10.3348/kjr.2018.19.4.545] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
18 Wang W, Zhang H, Wang L, Zhang S, Tang M. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1. Biochem Biophys Res Commun. 2016;473:987-992. [PMID: 27049311 DOI: 10.1016/j.bbrc.2016.04.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
19 Kudo M. Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma. Liver Cancer. 2016;5:235-244. [PMID: 27781196 DOI: 10.1159/000449335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
20 Luo SH, Chu JG, Huang H, Yao KC. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases 2019; 7(13): 1599-1610 [PMID: 31367619 DOI: 10.12998/wjcc.v7.i13.1599] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kudo M. Locoregional Therapy for Hepatocellular Carcinoma. Liver Cancer 2015;4:163-4. [PMID: 26674459 DOI: 10.1159/000367741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
22 Lee S, Kang TW. Reply to: "Influence of ablation technique on treatment failure for perivascular hepatocellular carcinoma". J Hepatol 2018;69:751-2. [PMID: 29870761 DOI: 10.1016/j.jhep.2018.05.032] [Reference Citation Analysis]
23 Banerjee J, Sun Y, Klink C, Gahrmann R, Niessen WJ, Moelker A, van Walsum T. Multiple-correlation similarity for block-matching based fast CT to ultrasound registration in liver interventions. Med Image Anal 2019;53:132-41. [PMID: 30772666 DOI: 10.1016/j.media.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
24 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Meershoek P, van den Berg NS, Lutjeboer J, Burgmans MC, van der Meer RW, van Rijswijk CSP, van Oosterom MN, van Erkel AR, van Leeuwen FWB. Assessing the value of volume navigation during ultrasound-guided radiofrequency- and microwave-ablations of liver lesions. Eur J Radiol Open 2021;8:100367. [PMID: 34286051 DOI: 10.1016/j.ejro.2021.100367] [Reference Citation Analysis]
26 Huang PC, Chaney EJ, Iyer RR, Spillman DR Jr, Odintsov B, Sobh NA, Boppart SA. Interstitial magnetic thermotherapy dosimetry based on shear wave magnetomotive optical coherence elastography. Biomed Opt Express 2019;10:539-51. [PMID: 30800498 DOI: 10.1364/BOE.10.000539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 Pusceddu C, Melis L, Ballicu N, Sotgia B, Melis M, Sanna V, Meloni GB, Porcu A, Fancellu A. Percutaneous Microwave Ablation Under CT Guidance for Hepatocellular Carcinoma: a Single Institutional Experience. J Gastrointest Cancer. 2018;49:295-301. [PMID: 28530021 DOI: 10.1007/s12029-017-9951-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
28 Giorgio A, Merola MG, Montesarchio L, Merola F, Gatti P, Coppola C, Giorgio V, Calisti G. Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years. Br J Radiol 2017;90:20160804. [PMID: 28402124 DOI: 10.1259/bjr.20160804] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
29 Camacho JC, Petre EN, Sofocleous CT. Thermal Ablation of Metastatic Colon Cancer to the Liver. Semin Intervent Radiol 2019;36:310-8. [PMID: 31680722 DOI: 10.1055/s-0039-1698754] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
30 Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L. Transarterial radioembolization for hepatocellular carcinoma: a review. J Hepatocell Carcinoma 2016;3:25-9. [PMID: 27574589 DOI: 10.2147/JHC.S50359] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
31 Iezzi R, Pompili M, Posa A, Carchesio F, Siciliano M, Annicchiarico BE, Agnes S, Giuliante F, Garcovich M, Cerrito L, Ponziani FR, Basso M, Cassano A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Manfredi R; HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? Eur J Radiol 2019;114:32-7. [PMID: 31005173 DOI: 10.1016/j.ejrad.2019.02.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
32 Hwang SH, Hong SB, Park S, Han K, Park YN, Kim SY, Park MS. Subcentimeter hepatocellular carcinoma in treatment-naïve patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI. Eur Radiol 2021;31:2321-31. [PMID: 33044650 DOI: 10.1007/s00330-020-07329-z] [Reference Citation Analysis]
33 Liu Z, Yang D, Li Y, Jiao Y, Lv G. HN1 as a diagnostic and prognostic biomarker for liver cancer. Biosci Rep 2020;40:BSR20200316. [PMID: 32700728 DOI: 10.1042/BSR20200316] [Reference Citation Analysis]
34 Mitani H, Naito A, Chosa K, Kodama H, Sumida M, Moriya T, Awai K. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome. Minim Invasive Ther Allied Technol 2021;:1-8. [PMID: 34726557 DOI: 10.1080/13645706.2021.1995436] [Reference Citation Analysis]
35 van Amerongen MJ, Mariappan P, Voglreiter P, Flanagan R, Jenniskens SFM, Pollari M, Kolesnik M, Moche M, Fütterer JJ. Software-based planning of ultrasound and CT-guided percutaneous radiofrequency ablation in hepatic tumors. Int J Comput Assist Radiol Surg 2021;16:1051-7. [PMID: 33974224 DOI: 10.1007/s11548-021-02394-1] [Reference Citation Analysis]
36 Han R, Liu Q, Lu Y, Peng J, Pan M, Wang G, Chen W, Xiao Y, Yang C, Qian Z. Tumor microenvironment-responsive Ag2S-PAsp(DOX)-cRGD nanoparticles-mediated photochemotherapy enhances the immune response to tumor therapy. Biomaterials 2021;281:121328. [PMID: 34953333 DOI: 10.1016/j.biomaterials.2021.121328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
37 Kudo M. Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update. Liver Cancer. 2016;6:1-12. [PMID: 27995082 DOI: 10.1159/000449342] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
38 Shi R, Liu Z. RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway. Cancer Cell Int 2022;22:150. [PMID: 35410346 DOI: 10.1186/s12935-022-02555-5] [Reference Citation Analysis]
39 Dou Y, Hynynen K, Allen C. To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes. Journal of Controlled Release 2017;249:63-73. [DOI: 10.1016/j.jconrel.2017.01.025] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 15.6] [Reference Citation Analysis]
40 Yuan Z, Xing A, Zheng J, Li W. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma. International Journal of Hyperthermia 2019;36:159-67. [DOI: 10.1080/02656736.2018.1542510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
41 He XQ, Zhang YF, Yu JJ, Gan YY, Han NN, Zhang MX, Ge W, Deng JJ, Zheng YF, Xu XM. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway. Tumour Biol 2017;39:1010428317695971. [PMID: 28347229 DOI: 10.1177/1010428317695971] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
42 Lin CC, Cheng YT, Chen M WT, Lin SM. The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2. Liver Cancer 2016;5:8-20. [PMID: 26989656 DOI: 10.1159/000367755] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
43 Rodrigues DB, Stauffer PR, Eisenbrey J, Beckhoff V, Hurwitz MD. Oncologic Applications of Magnetic Resonance Guided Focused Ultrasound. In: Wong JY, Schultheiss TE, Radany EH, editors. Advances in Radiation Oncology. Cham: Springer International Publishing; 2017. pp. 69-108. [DOI: 10.1007/978-3-319-53235-6_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
44 Mikaiel S, Simonelli J, Li X, Lee Y, Lee YS, Sung K, Lu DS, Tsao T, Wu HH. MRI‐guided targeted needle placement during motion using hydrostatic actuators. Int J Med Robotics Comput Assist Surg 2020;16. [DOI: 10.1002/rcs.2041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Korean Society of Abdominal Radiology. Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology. Korean J Radiol 2017;18:427-43. [PMID: 28458595 DOI: 10.3348/kjr.2017.18.3.427] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
46 Bo XW, Xu HX, Wang D, Guo LH, Sun LP, Li XL, Zhao CK, He YP, Liu BJ, Li DD, Zhang K. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol 2016;89:20160379. [PMID: 27626506 DOI: 10.1259/bjr.20160379] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
47 Zhan Y, Zhou F, Yu X, Luo F, Liu F, Liang P, Cheng Z, Han Z, Yu J. Quantitative dynamic contrast-enhanced ultrasound may help predict the outcome of hepatocellular carcinoma after microwave ablation. International Journal of Hyperthermia 2018;35:105-11. [DOI: 10.1080/02656736.2018.1483533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
48 Kim S, Kang T, Kim M, Lee M, Cho S, Paik Y, Kim M. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation. Clinical Radiology 2018;73:216.e1-8. [DOI: 10.1016/j.crad.2017.07.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]